Mice Brain nitric oxide synthase response induced by anaesthetics and other porphyrinogenic drugs

por Lavandera, J., Batlle, A., Buzaleh, A.M.

Cytochrome P450 expression in mouse brain: Specific isoenzymes involved in Phase i metabolizing system of porphyrinogenic agents in both microsomes and mitochondria

por Lavandera, J., Ruspini, S., Batlle, A., Buzaleh, A.M.

Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system

por Sampayo, R., Lavandera, J.V., Batlle, A., Buzaleh, A.M.

CYP2D6 polymorphisms in patients with porphyrias

por Lavandera, J.V., Parera, V.E., Batlle, A., Buzaleh, A.M.

Metabolization of porphyrinogenic agents in brain: Involvement of the Phase I drug metabolizing system. A comparative study in liver and kidney

por Lavandera, J.V., Batlle, A.M.D.C., Buzaleh, A.M.

Glutamatergic system: Another target for the action of porphyrinogenic agents

por Lavandera, J.V., Fossati, M., Azcurra, J., Batlle, A., Buzaleh, A.M.

Efecto diferencial de la fuente de grasas dietarias sobre las alteraciones hepáticas inducidas por los conjugados del ácido linoleico en ratones

por Scalerandi, M.V., González, M.A., Saín, J., Reus, V., Lavandera, J., Bernal, C.A.
Publicado 2014

Pleiotropic effects of 5-aminolevulinic acid in mouse brain

por Lavandera, J., Rodríguez, J., Ruspini, S., Meiss, R., Zuccoli, J.R., Martínez, M.D.C., Gerez, E., Batlle, A., Buzaleh, A.M.

Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs

por Ruspini, S.F., Zuccoli, J.R., Lavandera, J.V., Martínez, M.D.C., Oliveri, L.M., Gerez, E.N., Batlle, A.M.D.C., Buzaleh, A.M.

Heme metabolism: The janus nature of precursorsand porphyrins

por Rossetti, M.V., Buzaleh, A.M., Parera, V.E., Fukuda, H., Lombardo, M.E., Lavandera, J., Gerez, E.N., Melito, V.A., Zuccoli, J.R., Ruspini, S.F., Puente, V.R., Diez, B.A., Teijo, M.J., Cerbino, G.N., Varela, L.S., Guolo, M.N., Del Carmen Batlle, A.M.